| 1 |
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
Siew C. Ng, Hai Yun Shi, Nima Hamidi et al. · The Lancet
Review |
16 Oct 2017 |
6,147 |
| 2 |
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Daniel J. Klionsky et al. · Autophagy
Open access2,467 authors |
2 Jan 2016 |
6,023 |
| 3 |
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al. · Journal of Hepatology
Open access |
8 Apr 2020 |
4,540 |
| 4 |
Recycling lithium-ion batteries from electric vehicles
Gavin Harper, Roberto Sommerville, Emma Kendrick et al. · Nature
Open access |
6 Nov 2019 |
3,845 |
| 5 |
TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods
Professor Gary S. Collins et al. · BMJ
Open access |
16 Apr 2024 |
3,581 |
| 6 |
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Mary Eugenia Rinella et al. · Hepatology
Open access |
22 Jun 2023 |
3,191 |
| 7 |
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
Veeru Kasivisvanathan et al. · New England Journal of Medicine
Open access |
19 Mar 2018 |
3,101 |
| 8 |
PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies
Robert F. Wolff, Karel G.M. Moons, Richard D Riley et al. · Annals of Internal Medicine
Open access |
31 Dec 2018 |
2,929 |
| 9 |
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
Philip Noel Newsome, Kristine Buchholtz, Kenneth J. Cusi et al. · New England Journal of Medicine
Open access |
13 Nov 2020 |
2,006 |
| 10 |
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
Stephen A. Harrison et al. · New England Journal of Medicine
Open access |
7 Feb 2024 |
1,963 |
| 11 |
A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging: a systematic review and meta-analysis
Xiaoxuan Liu, Livia Faes, Aditya U. Kale et al. · The Lancet Digital Health
ReviewOpen access |
25 Sep 2019 |
1,936 |
| 12 |
Resolving the fibrotic niche of human liver cirrhosis at single-cell level
Prakash Ramachandran et al. · Nature
Open access |
9 Oct 2019 |
1,838 |
| 13 |
PROBAST: A Tool to Assess Risk of Bias and Applicability of Prediction Model Studies: Explanation and Elaboration
Karel G.M. Moons, Robert F. Wolff, Richard D Riley et al. · Annals of Internal Medicine
Open access |
31 Dec 2018 |
1,730 |
| 14 |
Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry
Fan Zhang et al. · Nature Immunology
Open access |
6 May 2019 |
1,462 |
| 15 |
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Peter J. Eddowes, M. Sasso, Michael E. Allison et al. · Gastroenterology
Open access |
25 Jan 2019 |
1,430 |
| 16 |
Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension
Xiaoxuan Liu et al. · Nature Medicine
Open access |
Sep 2020 |
1,301 |
| 17 |
Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection
Jacqueline Dinnes, Jonathan J Deeks, Ada Adriano et al. · Cochrane Database of Systematic Reviews
Open access |
26 Aug 2020 |
1,263 |
| 18 |
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Zobair M. Younossi et al. · The Lancet
Open access388 authors |
Dec 2019 |
1,260 |
| 19 |
2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC)
Giuseppe Mancia et al. · Journal of Hypertension
|
29 Aug 2013 |
1,203 |
| 20 |
Symptoms and risk factors for long COVID in non-hospitalized adults
Anuradhaa Subramanian et al. · Nature Medicine
Open access |
25 Jul 2022 |
1,160 |
| 21 |
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
Lennard Y. W. Lee et al. · The Lancet
Open access |
28 May 2020 |
1,146 |
| 22 |
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment
Tim Raine et al. · Journal of Crohn s and Colitis
Open access |
7 Oct 2021 |
1,105 |
| 23 |
Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis
Ren Mao, Yun Qiu, Jin-Shen He et al. · The Lancet. Gastroenterology & hepatology
ReviewOpen access |
12 May 2020 |
1,091 |
| 24 |
Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
Rod S. Taylor, Rebecca J. Taylor, Susan E Bayliss et al. · Gastroenterology
ReviewOpen access |
4 Feb 2020 |
1,068 |
| 25 |
Symptoms, complications and management of long COVID: a review
Olalekan Lee Aiyegbusi, Sarah Hughes, Grace Turner et al. · Journal of the Royal Society of Medicine
Open access |
15 Jul 2021 |
1,017 |
| 26 |
The systemic immune response to trauma: an overview of pathophysiology and treatment
Janet M. Lord, Mark J. Midwinter, Yen‐Fu Chen et al. · The Lancet
Open access |
Oct 2014 |
862 |
| 27 |
The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis
Lauren L. O’Mahoney et al. · EClinicalMedicine
ReviewOpen access |
Dec 2022 |
845 |
| 28 |
The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
Leisha A. Emens, Gary Middleton · Cancer Immunology Research
Open access |
May 2015 |
843 |
| 29 |
Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls
Nick Craddock et al. · Nature
Open access217 authors |
30 Mar 2010 |
824 |
| 30 |
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
Philip Noel Newsome et al. · The Lancet. Gastroenterology & hepatology
Open access |
3 Feb 2020 |
797 |
| 31 |
European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
Hein Heidbüchel, Peter B. Verhamme, Marco Alings et al. · EP Europace
Open access |
26 Apr 2013 |
795 |
| 32 |
Antibody tests for identification of current and past infection with SARS‐CoV‐2
Geppert, Julia et al. · LSTM Online Archive (Liverpool School of Tropical Medicine)
|
17 Nov 2022 |
778 |
| 33 |
Advancing the global public health agenda for NAFLD: a consensus statement
Jeffrey Victor Lazarus et al. · Nature Reviews Gastroenterology & Hepatology
ReviewOpen access221 authors |
27 Oct 2021 |
768 |
| 34 |
PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods
Karel G.M. Moons et al. · BMJ
Open access |
24 Mar 2025 |
767 |
| 35 |
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
Simon I Hay et al. · The Lancet
Open access2,780 authors |
Oct 2025 |
762 |
| 36 |
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis
Stefano Alivernini et al. · Nature Medicine
Open access |
29 Jun 2020 |
750 |
| 37 |
EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies
Manuel Ramos‐Casals et al. · Annals of the Rheumatic Diseases
Open access |
31 Oct 2019 |
736 |
| 38 |
Preferred reporting items for systematic review and meta-analysis of diagnostic test accuracy studies (PRISMA-DTA): explanation, elaboration, and checklist
Jean‐Paul Salameh et al. · BMJ
ReviewOpen access |
14 Aug 2020 |
733 |
| 39 |
Antibody tests for identification of current and past infection with SARS-CoV-2
Jonathan J Deeks, Jacqueline Dinnes, Yemisi Takwoingi et al. · Cochrane Database of Systematic Reviews
Open access |
25 Jun 2020 |
733 |
| 40 |
Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension
Samantha Cruz Rivera et al. · Nature Medicine
Open access |
Sep 2020 |
726 |
| 41 |
Evaluation of clinical prediction models (part 1): from development to external validation
Professor Gary S. Collins, Paula Dhiman, Jie Ma et al. · BMJ
Open access |
8 Jan 2024 |
708 |
| 42 |
The importance of patient-reported outcomes in clinical trials and strategies for future optimization
Rebecca Mercieca‐Bebber, Madeleine Trudy King, Melanie Jane Calvert et al. · Patient Related Outcome Measures
Open access |
31 Oct 2018 |
695 |
| 43 |
The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
Tom H Karlsen et al. · The Lancet
Open access |
2 Dec 2021 |
653 |
| 44 |
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection
Jacqueline Dinnes et al. · Cochrane Database of Systematic Reviews
Open access |
24 Mar 2021 |
628 |
| 45 |
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease
Thomas Struyf, Jonathan J Deeks, Jacqueline Dinnes et al. · Cochrane Database of Systematic Reviews
Open access |
7 Jul 2020 |
616 |
| 46 |
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
Lennard Y. W. Lee et al. · The Lancet Oncology
Open access171 authors |
24 Aug 2020 |
601 |
| 47 |
Notch signalling drives synovial fibroblast identity and arthritis pathology
Kevin S. Wei et al. · Nature
Open access |
22 Apr 2020 |
561 |
| 48 |
Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease
Reenam S. Khan, Fernando Bril, Kenneth J. Cusi et al. · Hepatology
Open access |
17 Dec 2018 |
546 |
| 49 |
Guidelines on the management of abnormal liver blood tests
Philip Noel Newsome, Rob Cramb, Suzanne M. Davison et al. · Gut
Open access |
9 Nov 2017 |
544 |
| 50 |
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis
Tobias J. Weismüller et al. · Gastroenterology
Open access |
6 Mar 2017 |
531 |